These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17516869)

  • 1. Managing multiple and extensively drug-resistant tuberculosis and HIV.
    Padayatchi N; Friedland G
    Expert Opin Pharmacother; 2007 Jun; 8(8):1035-7. PubMed ID: 17516869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.
    Ballif M; Nhandu V; Wood R; Dusingize JC; Carter EJ; Cortes CP; McGowan CC; Diero L; Graber C; Renner L; Hawerlander D; Kiertiburanakul S; Du QT; Sterling TR; Egger M; Fenner L;
    Int J Tuberc Lung Dis; 2014 Nov; 18(11):1327-36. PubMed ID: 25299866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential drug-drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals.
    Mukonzo J; Aklillu E; Marconi V; Schinazi RF
    Int J Infect Dis; 2019 Jun; 83():98-101. PubMed ID: 30991140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
    Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
    JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
    Koenig R
    Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study.
    Bastard M; Sanchez-Padilla E; du Cros P; Khamraev AK; Parpieva N; Tillyashaykov M; Hayrapetyan A; Kimenye K; Khurkhumal S; Dlamini T; Perez SF; Telnov A; Hewison C; Varaine F; Bonnet M
    PLoS One; 2018; 13(3):e0193491. PubMed ID: 29518098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Multiple drug resistance: a threat for tuberculosis control].
    Cardoso EM
    Rev Panam Salud Publica; 2004 Jul; 16(1):68-73. PubMed ID: 15333267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of drug resistantTB in patients with HIV co-infection.
    Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
    Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of multidrug-resistant and extensively drug-resistant TB: global perspectives with a focus on sub-Saharan Africa.
    Migliori GB; Dheda K; Centis R; Mwaba P; Bates M; O'Grady J; Hoelscher M; Zumla A
    Trop Med Int Health; 2010 Sep; 15(9):1052-66. PubMed ID: 20545927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of misfortunes.
    Cohen J
    Science; 2013 Feb; 339(6122):898-903. PubMed ID: 23430629
    [No Abstract]   [Full Text] [Related]  

  • 12. The re-emergence of tuberculosis.
    Porter JD; McAdam KP
    Annu Rev Public Health; 1994; 15():303-23. PubMed ID: 8054087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis, drug use and HIV infection in Central Asia: an urgent need for attention.
    Schluger NW; El-Bassel N; Hermosilla S; Terlikbayeva A; Darisheva M; Aifah A; Galea S
    Drug Alcohol Depend; 2013 Nov; 132 Suppl 1():S32-6. PubMed ID: 23928052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana.
    Kenyon TA; Mwasekaga MJ; Huebner R; Rumisha D; Binkin N; Maganu E
    Int J Tuberc Lung Dis; 1999 Jan; 3(1):4-11. PubMed ID: 10094163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of drug-resistant tuberculosis: analysis of 11 countries.
    Espinal MA; Laserson K; Camacho M; Fusheng Z; Kim SJ; Tlali RE; Smith I; Suarez P; Antunes ML; George AG; Martin-Casabona N; Simelane P; Weyer K; Binkin N; Raviglione MC
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):887-93. PubMed ID: 11605880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
    Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
    Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of difficult multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: update 2012.
    Chang KC; Yew WW
    Respirology; 2013 Jan; 18(1):8-21. PubMed ID: 22943408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis, a re-emergent disease.
    Valadas E; Antunes F
    Eur J Radiol; 2005 Aug; 55(2):154-7. PubMed ID: 15905058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.